Next Article in Journal
Flexible Hydrophobic [email protected]@AuNPs Stripes for Highly Sensitive SERS Detection of Methylene Blue Residue
Previous Article in Journal
Pulsed Fluidization of Nanosilica: Rigorous Evaluation of the Efficacy of Pulsation Frequency
Previous Article in Special Issue
Morphological Studies of Composite Spin [email protected]2 Nanoparticles
Article

Hypolipidemic Activity of Olive Oil-Based Nanostructured Lipid Carrier Containing Atorvastatin

1
Al Bilad Bank Scholarly Chair for Food and Security in Saudi Arabia, The Deanship of Scientific Research, The Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Alhofuf 36362, Saudi Arabia
2
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf 36362, Saudi Arabia
3
Department of Chemistry, College of Science, King Faisal University, Alhofuf 36362, Saudi Arabia
4
Department of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf 36362, Saudi Arabia
5
Department of Microbiology and Immunology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Mansoura 11152, Egypt
*
Author to whom correspondence should be addressed.
Academic Editors: Rosalia Bertorelli, Gemma Gutierrez and Maria Matos
Nanomaterials 2022, 12(13), 2160; https://0-doi-org.brum.beds.ac.uk/10.3390/nano12132160
Received: 25 May 2022 / Revised: 18 June 2022 / Accepted: 21 June 2022 / Published: 23 June 2022
(This article belongs to the Special Issue Micro/Nano Emulsions: Fabrication and Applications)
Currently, hyperlipidemia is a growing health issue that is considered a risk factor for obesity. Controlling body weight and modifying life style in most of cases are not adequate and the condition requires medical treatment. Statin drugs (mainly Atorvastatin (ATO)), have been used broadly and for long time as medications for handling higher levels of lipid, especially bad cholesterol, which accordingly controls the prevalence of obesity. Still, the obstacle that stands in front of any formulation is the poor solubility of the drug. Low solubility of ATO came up with poor absorption as well as poor bioavailability. This paved the way for the present study, which aimed to exploit nanotechnology and develop certain nanolipid carriers that could accommodate hydrophobic drugs, such as ATO. Nanostructured lipid carrier (NLC) containing ATO was fabricated using olive oil. Olive oil is natural plant oil possessing confirmed hypolipidemic activity that would help in improving the efficacy of the formulation. Via applying the Quality by Design (QbD) approach, one NLC formula was selected to be optimized based on appropriate size and higher entrapment. Optimized ATO-NLC was scrutinized for zeta potential, in vitro study and kinetic profile. Moreover, stability testing and in vivo hypolipidemic behavior was conducted. The optimized NLC formulation seemed to show particle size (254.23 nm) with neutral zeta potential (−1.77 mV) and entrapment efficiency (69.56%). The formulation could be prolonged for 12 h and provided higher % of release (97.17%). Stability testing confirmed the role of modifying the surface of the formulation with PEG-DSPE in providing a highly stable formulation that could withstand three months storage in two altered conditions. Ultimately, optimized ATO-NLC could successfully lower total cholesterol level in rats induced with obesity and fed a high-fat diet. Remarkably, ATO-NLC prepared with olive oil, in addition to shielding its surface, would provide a stable formulation that holds up the synergistic action between olive oil and ATO. View Full-Text
Keywords: hypolipidemic; obesity; olive oil; atorvastatin; nanostructured lipid carrier hypolipidemic; obesity; olive oil; atorvastatin; nanostructured lipid carrier
Show Figures

Figure 1

MDPI and ACS Style

Elsewedy, H.S.; Shehata, T.M.; Almostafa, M.M.; Soliman, W.E. Hypolipidemic Activity of Olive Oil-Based Nanostructured Lipid Carrier Containing Atorvastatin. Nanomaterials 2022, 12, 2160. https://0-doi-org.brum.beds.ac.uk/10.3390/nano12132160

AMA Style

Elsewedy HS, Shehata TM, Almostafa MM, Soliman WE. Hypolipidemic Activity of Olive Oil-Based Nanostructured Lipid Carrier Containing Atorvastatin. Nanomaterials. 2022; 12(13):2160. https://0-doi-org.brum.beds.ac.uk/10.3390/nano12132160

Chicago/Turabian Style

Elsewedy, Heba S., Tamer M. Shehata, Mervt M. Almostafa, and Wafaa E. Soliman. 2022. "Hypolipidemic Activity of Olive Oil-Based Nanostructured Lipid Carrier Containing Atorvastatin" Nanomaterials 12, no. 13: 2160. https://0-doi-org.brum.beds.ac.uk/10.3390/nano12132160

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop